Home - Products - Others - Other Targets - (3E,8Z,11Z)-Tetradeca-3,8,11-trienyl acetate

(3E,8Z,11Z)-Tetradeca-3,8,11-trienyl acetate

CAS No. 163041-94-9

(3E,8Z,11Z)-Tetradeca-3,8,11-trienyl acetate( —— )

Catalog No. M37467 CAS No. 163041-94-9

(3E,8Z,11Z)-Tetradeca-3,8,11-trienyl acetate ((3e,8z,11z)-Tetradecatrienyl Acetate) is an additive for tobacco products and a vegetable pest pheromone that can be used to capture pests in agriculture.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 37 In Stock
100MG 60 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (3E,8Z,11Z)-Tetradeca-3,8,11-trienyl acetate
  • Note
    Research use only, not for human use.
  • Brief Description
    (3E,8Z,11Z)-Tetradeca-3,8,11-trienyl acetate ((3e,8z,11z)-Tetradecatrienyl Acetate) is an additive for tobacco products and a vegetable pest pheromone that can be used to capture pests in agriculture.
  • Description
    (3E,8Z,11Z)-Tetradeca-3,8,11-trienyl acetate ((3e,8z,11z)-Tetradecatrienyl Acetate) is an additive for tobacco products and a vegetable pest pheromone that can be used to capture pests in agriculture.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    163041-94-9
  • Formula Weight
    250.38
  • Molecular Formula
    C16H26O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC\C=C/C\C=C/CCC\C=C\CCOC(C)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • [Ala286]-Calmodulin-...

    [Ala286]-Calmodulin-Dependent Protein Kinase II (281-302) is a modified fragment of calcium/calmodulin-dependent protein kinase II that contains the active domain of CaMKII and has an alanine substitution at position 286. [Ala286]-Calmodulin-Dependent Protein Kinase II (281-302) can be used to develop more potent CaMKII inhibitors.

  • Linzagolix

    Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis.

  • gp100 (457-466)

    gp100 (457-466)